Citation Impact
Citing Papers
Differential use of endoplasmic reticulum membrane for phagocytosis in J774 macrophages
2005 StandoutNobel
Alternative Zippering as an On-Off Switch for SNARE-Mediated Fusion
2009 StandoutScienceNobel
Mechanisms of Viral Membrane Fusion and Its Inhibition
2001
Human Immunodeficiency Virus Type 1 Env Trimer Immunization of Macaques and Impact of Priming with Viral Vector or Stabilized Core Protein
2008
Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus
2020 StandoutNobel
Maturation-Dependent HIV-1 Surface Protein Redistribution Revealed by Fluorescence Nanoscopy
2012 StandoutScienceNobel
Single Reconstituted Neuronal SNARE Complexes Zipper in Three Distinct Stages
2012 StandoutScienceNobel
SNARE Proteins: One to Fuse and Three to Keep the Nascent Fusion Pore Open
2012 StandoutScienceNobel
SNARE Function Analyzed in Synaptobrevin/VAMP Knockout Mice
2001 StandoutScienceNobel
Single-particle kinetics of influenza virus membrane fusion
2008
Computational design of closely related proteins that adopt two well-defined but structurally divergent folds
2020 StandoutNobel
Fusion of Cells by Flipped SNAREs
2003 StandoutScienceNobel
Convergence and divergence in the mechanism of SNARE binding by Sec1/Munc18-like proteins
2002 StandoutNobel
The ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide.
1996
HIV-1 Gag Processing Intermediates Trans-dominantly Interfere with HIV-1 Infectivity
2009
Three-dimensional solution structure of the 44kDa ectodomain of SIV gp41
1998
A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion
1993 StandoutNobel
Rethinking amide bond synthesis
2011 StandoutNature
Structure of the Hemagglutinin Precursor Cleavage Site, a Determinant of Influenza Pathogenicity and the Origin of the Labile Conformation
1998
Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate
2005
HIV Entry and Its Inhibition
1998
Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution
1998 StandoutNature
A trimeric structural domain of the HIV-1 transmembrane glycoprotein
1995
Immunotherapy of Hematologic Malignancy
2003
Morphological Changes and Fusogenic Activity of Influenza Virus Hemagglutinin
1998
Crystal Structure of HIV-1 gp41 Including Both Fusion Peptide and Membrane Proximal External Regions
2010
Atomic structure of the ectodomain from HIV-1 gp41
1997 StandoutNature
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
1998 StandoutNature
Crystal Structure of the Ebola Virus Membrane Fusion Subunit, GP2, from the Envelope Glycoprotein Ectodomain
1998
SNAREpins: Minimal Machinery for Membrane Fusion
1998 StandoutNobel
Human Antibody Responses to HIV Type 1 Glycoprotein 41 Cloned in Phage Display Libraries Suggest Three Major Epitopes Are Recognized and Give Evidence for Conserved Antibody Motifs in Antigen Binding
1996
Core Structure of gp41 from the HIV Envelope Glycoprotein
1997 Standout
Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence
1997
The paramyxovirus fusion protein forms an extremely stable core trimer: structural parallels to influenza virus haemagglutinin and HIV-1 gp41
1999
The Energetics of Membrane Fusion from Binding, through Hemifusion, Pore Formation, and Pore Enlargement
2004
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Antibody neutralization and escape by HIV-1
2003 StandoutNature
The karyogamy gene KAR2 and novel proteins are required for ER-membrane fusion
1994 StandoutNobel
Complexins Regulate a Late Step in Ca2+-Dependent Neurotransmitter Release
2001 StandoutNobel
Membrane Fusion
2003 StandoutNobel
Structural Basis for Paramyxovirus-Mediated Membrane Fusion
1999
Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination
2002
HIV as the cause of AIDS
1996 StandoutNobel
Enveloped viruses: A common mode of membrane fusion?
1997
Dissection of a retrovirus envelope protein reveals structural similarity to influenza hemagglutinin
1995
A spring-loaded mechanism for the conformational change of influenza hemagglutinin
1993
The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus Infection
1995
How Do Viruses Enter Cells? The HIV Coreceptors Teach Us a Lesson of Complexity
1997
What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (Review)
1997
Mutations That Destabilize the gp41 Core Are Determinants for Stabilizing the Simian Immunodeficiency Virus-CPmac Envelope Glycoprotein Complex
2002
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
2009
HIV fusion and its inhibition
2001
Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
1997 StandoutNatureNobel
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
1998
Synthetic therapeutic peptides: science and market
2009
Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins
1999
Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
2013
Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions
1992
Structural basis of receptor recognition by SARS-CoV-2
2020 StandoutNature
Multimerization Potential of the Cytoplasmic Domain of the Human Immunodeficiency Virus Type 1 Transmembrane Glycoprotein gp41
2000
Selective Activation of Cognate SNAREpins by Sec1/Munc18 Proteins
2007 StandoutNobel
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Inhibition of HIV type 1 infectivity by constrained α-helical peptides: Implications for the viral fusion mechanism
1997
Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope
2004
Structure of the HIV-1 gp41 Membrane-Proximal Ectodomain Region in a Putative Prefusion Conformation,
2009
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
1999 StandoutNobel
Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold
2011 StandoutScienceNobel
Postbinding events mediated by human immunodeficiency virus type 1 are sensitive to modifications in the D4-transmembrane linker region of CD4
1996
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity
1997
Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies
2004
Influenza hemagglutinin is spring-loaded by a metastable native conformation
1997
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein
1993
Atomic structure of a thermostable subdomain of HIV-1 gp41
1997
Functional role of the zipper motif region of human immunodeficiency virus type 1 transmembrane protein gp41
1994
SNAREpin/Munc18 promotes adhesion and fusion of large vesicles to giant membranes
2008 StandoutNobel
A Core Trimer of the Paramyxovirus Fusion Protein: Parallels to Influenza Virus Hemagglutinin and HIV-1 gp41
1998
Mapping epitopes and antigenicity by site-directed masking
2006 StandoutNobel
Fusion Peptides Derived from the HIV Type 1 Glycoprotein 41 Associate within Phospholipid Membranes and Inhibit Cell-Cell Fusion
1997
Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: Conserved helical interactions underlie the broad inhibitory activity of gp41 peptides
1998
A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion
1995
Impaired insulin secretion and glucose intolerance in synaptotagmin-7 null mutant mice
2008 StandoutNobel
Crosslinked HIV-1 envelope–CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques
2002
The specificity of SNARE-dependent fusion is encoded in the SNARE motif
2004 StandoutNobel
Determinants of Human Immunodeficiency Virus Type 1 Resistance to gp41-Derived Inhibitory Peptides
1998
Intracellular calcium dependence of large dense-core vesicle exocytosis in the absence of synaptotagmin I
2001 StandoutNobel
De novo design of covalently constrained mesosize protein scaffolds with unique tertiary structures
2017 StandoutNobel
Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin
2000 Standout
Membrane Fusion and Exocytosis
1999 StandoutNobel
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
2020 StandoutScience
Oligomeric Modeling and Electrostatic Analysis of the gp120 Envelope Glycoprotein of Human Immunodeficiency Virus
2000
Peptide Inhibitors of Flavivirus Entry Derived from the E Protein Stem
2010
VIRUS-CELL AND CELL-CELL FUSION
1996
Pathogenesis of human immunodeficiency virus infection
1993
CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1
1997
Influenza-virus membrane fusion by cooperative fold-back of stochastically induced hemagglutinin intermediates
2013
Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in Escherichia coli
1997
HIV-1 gp41 Tertiary Structure Studied by EPR Spectroscopy
1996
Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination
2002
Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-Å resolution
1999
Cationic microparticles are a potent delivery system for a HCV DNA vaccine
2004 StandoutNobel
The Membrane-Proximal Tryptophan-Rich Region of the HIV Glycoprotein, gp41, Forms a Well-Defined Helix in Dodecylphosphocholine Micelles,
2001
HIV-1 Membrane Fusion Mechanism: Structural Studies of the Interactions between Biologically-Active Peptides from gp41
1996
The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex
2003
A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses.
1995
Control over overall shape and size in de novo designed proteins
2015 StandoutNobel
Chemical Reaction-Inspired Crystal Growth of a Coordination Polymer toward Morphology Design and Control
2006 StandoutNobel
Protein grafting of an HIV-1-inhibiting epitope
2003
Protein Design of an HIV-1 Entry Inhibitor
2001 Science
Regulation of Human Immunodeficiency Virus Type 1 Env-Mediated Membrane Fusion by Viral Protease Activity
2003
Membrane Fusion: Grappling with SNARE and SM Proteins
2009 StandoutScienceNobel
Dilation of the Human Immunodeficiency Virus–1 Envelope Glycoprotein Fusion Pore Revealed by the Inhibitory Action of a Synthetic Peptide from gp41
1998
Constrained Peptides as Miniature Protein Structures
2012
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
1998 StandoutScience
Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.
1996
Quantitative Measurements of Recombinant HIV Surface Glycoprotein 120 Binding to Several Glycosphingolipids Expressed in Planar Supported Lipid Bilayers
2002
Inhibitors of human immunodeficiency virus integrase.
1993 StandoutNobel
Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy
2002 Standout
Amino Acid Substitutions within the Leucine Zipper Domain of the Murine Coronavirus Spike Protein Cause Defects in Oligomerization and the Ability To Induce Cell-to-Cell Fusion
1999
Mutational Analysis of Residues in the Coiled-Coil Domain of Human Immunodeficiency Virus Type 1 Transmembrane Protein gp41
1998
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
A SNARE required for retrograde transport to the endoplasmic reticulum
2003 StandoutNobel
Elicitation of structure-specific antibodies by epitope scaffolds
2010 StandoutNobel
Prospects for the Future
2002 StandoutScienceNobel
Structural Analysis of HIV-1 Maturation Using Cryo-Electron Tomography
2010
Regulation of membrane fusion by the membrane-proximal coil of the t-SNARE during zippering of SNAREpins
2002 StandoutNobel
Works of Carl Wild being referenced
Structural Rearrangements in the Transmembrane Glycoprotein after Receptor Binding
1994
Capture of an early fusion-active conformation of HIV-1 gp41
1998
Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogs: direct correlation of antiviral potency with molecular weight
1991
Induction of Potent Immune Responses by Cationic Microparticles with Adsorbed Human Immunodeficiency Virus DNA Vaccines
2001
Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.
1994
PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing
2003
Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex.
1994
Immunogenicity and Protective Efficacy of Oligomeric Human Immunodeficiency Virus Type 1 gp140
2001
The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable Region
2001
Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human immunodeficiency virus type 1 transmembrane protein gp41
1996
A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.
1992
Peptides Corresponding to the Heptad Repeat Motifs in the Transmembrane Protein (gp41) of Human Immunodeficiency Virus Type 1 Elicit Antibodies to Receptor-Activated Conformations of the Envelope Glycoprotein
2001